CrossrefInfokarte
CON: Therapy for a Patient With Platinum–Resistant/Refractory Ovarian Cancer Should Not be Selected Based on Results of an In Vitro Extreme Drug Sensitivity/Resistance Assay
Clinical Ovarian Cancer · 2011
DOI: 10.1016/j.cloc.2012.02.003 ↗Abstract
Kein Abstract verfügbar.
EUVIMED